Dupixent is alleged to cause or accelerate Cutaneous T-cell Lymphoma (“CTCL”) which is a rare and serious white blood cell cancer. Dupixent is prescribed for atopic dermatitis, eczema, asthma and other allergic conditions, including: nasal polyps/chronic sinusitis, eosinophilic esophagitis, prurigo nodularis and chronic obstructive pulmonary disease “(“COPD”). Dupixent acts to mask or accelerat…
Read moreSome premature babies who consume certain Similac and Enfamil formulas may be at risk of developing a rare intestinal disorder known as Necrotizing Enterocolitis (NEC).
NEC is a medical condition that primarily affects premature infants, although it can occur in full-term infants as well. This serious gastrointestinal disease involves inflammation and damage to the intestines. This can kill th…